OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 19 results. Expanded Search
Genes match for NM_024586   Similar terms to NM_024586

   OSBPL9   (FLJ12492;FLJ14629;FLJ14801;FLJ32055;FLJ34384;MGC15035;ORP9;ORP-9;OSBP4;)

Citation  Cited in Publication(s)       15,000 ORF clones at $98 each


TA311524  Anti-OSBPL9 Antibody
1 Image
Description:   Goat Anti-ORP9 / OSBPL9 Antibody
Applications:  IHC
Reactivity:  Test: Human. Expected from seq similarity: Human, Mouse, Rat, Dog, Pig, Cow
spacer
AP22570PU-N  Anti-OSBPL9 Antibody
2 Images
Description:  Goat Polyclonal Anti-OSBPL9 Antibody, Purified
Applications:  IHC
Reactivity: Can, Hu, Ms
spacer
|<<     <<      >>     >>|   total pages:1
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  RC224905     Human Clone pCMV6-Entry Myc-DDK OSBPL9 (Myc-DDK-tagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6 1090 5-6 weeks
  RC224905L1V     Human LentiORF Particles pLenti-C-Myc-DDK Myc-DDK Lenti ORF particles, OSBPL9 (Myc-DDK-tagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6, 200ul, >10^7 TU/mL 1660 10-11 weeks
  RC224905L2V     Human LentiORF Particles pLenti-C-mGFP mGFP Lenti ORF particles, OSBPL9 (mGFP-tagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6, 200ul, >10^7 TU/mL 1820 10-11 weeks
  RC224905L1     Human Lenti-ORF pLenti-C-Myc-DDK Myc-DDK Lenti-ORF clone of OSBPL9 (Myc-DDK-tagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6, (10ug) 1260 7-8 weeks
  RC224905L2     Human Lenti-ORF pLenti-C-mGFP mGFP Lenti-ORF clone of OSBPL9 (mGFP-tagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6, (10ug) 1380 7-8 weeks
  RG224905     Human Clone pCMV6-AC-GFP TurboGFP OSBPL9 (GFP-tagged) - Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6 1210 In Stock
  SC110752     Human Clone pCMV6-XL5 No Tags OSBPL9 (untagged)-Human oxysterol binding protein-like 9 (OSBPL9), transcript variant 6 1370 In Stock
SKU   Category   Format   Vector   Description   $ Price   Availability  
  TL302749V     Human shRNA Lentiviral particles pGFP-C-shLenti OSBPL9 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^6 TU/ml. 1200 5 weeks
  TL302749     Human shRNA Lentiviral Plasmid pGFP-C-shLenti OSBPL9 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TG302749     Human shRNA Retroviral Plasmids pGFP-V-RS OSBPL9 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 2 Weeks
  TF302749     Human shRNA Retroviral Plasmids pRFP-C-RS OSBPL9 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 2 Weeks
  TR302749     Human shRNA Retroviral Plasmids pRS OSBPL9 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 2 Weeks
  SR314463     Human siRNA OSBPL9 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 390 2 weeks
  TL512816     Mouse shRNA Lentiviral Plasmid pGFP-C-shLenti OSBPL9 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TL703692     Rat shRNA Lentiviral Plasmid pGFP-C-shLenti OSBPL9 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
SKU   Category  
Description   $ Price   Availability  
  SC208936     3'-UTR Clone pMirTarget 3`UTR clone of oxysterol binding protein-like 9 (OSBPL9) transcript variant 6 for miRNA target validation 510 3-4 weeks
SKU   Category   Description   $ Price   Availability  
  KN203396     CRISPR OSBPL9 - human gene knockout kit via CRISPR 1200 4 Weeks
Circling Loader
Loading message
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title